microRNA-622 upregulates cell cycle process by targeting FOLR2 to promote CRC proliferation

Yuehong Chen,Feng Liu,Xinhua Chen,Wenyi Li,Kejun Li,Hailang Cai,Shunyi Wang,Honglei Wang,Ke Xu,Chenxi Zhang,Shengzhi Ye,Yunhao Shen,Tingyu Mou,Shumin Cai,Jianwei Zhou,Jiang Yu
DOI: https://doi.org/10.1186/s12885-023-11766-6
IF: 4.638
2024-01-02
BMC Cancer
Abstract:Abstract Background Epigenetic alterations contribute greatly to the development and progression of colorectal cancer, and effect of aberrant miR-622 expression is still controversial. This study aimed to discover miR-622 regulation in CRC proliferation. Methods miR-622 expression and prognosis were analyzed in clinical CRC samples from Nanfang Hospital. miR-622 regulation on cell cycle and tumor proliferation was discovered, and FOLR2 was screened as functional target of miR-622 using bioinformatics analysis, which was validated via dual luciferase assay and gain-of-function and loss-of-function experiments both in vitro and in vivo. Results miR-622 overexpression in CRC indicated unfavorable prognosis and it regulated cell cycle to promote tumor growth both in vitro and in vivo. FOLR2 is a specific, functional target of miR-622, which negatively correlates with signature genes in cell cycle process to promote CRC proliferation. Conclusions miR-622 upregulates cell cycle process by targeting FOLR2 to promote CRC proliferation, proposing a novel mechanism and treatment target in CRC epigenetic regulation of miR-622.
oncology
What problem does this paper attempt to address?